Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia

Hepatocellular carcinoma (HCC) can be produced from aflatoxin B1 (AFB1) administration. Although berberine (BER) acts as an anticancer agent and can counteract the AFB1 effect, it has low bioavailability. Nanotechnology can overcome this problem. This research aimed to synthesize berberine nanoparti...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedr, Sarah M., Ghareeb, Doaa A., Fathy, Shadia A., Hamdy, Germine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413506/
https://www.ncbi.nlm.nih.gov/pubmed/37559065
http://dx.doi.org/10.1186/s40360-023-00683-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413506/
https://www.ncbi.nlm.nih.gov/pubmed/37559065
http://dx.doi.org/10.1186/s40360-023-00683-w

Ejemplares similares